Pacira | PCRX - 净收入

金融业

USD

USD 1.21B

现金及等价物

USD 144.31M

USD 50.74M

USD 514.96M

USD 108.79M

USD 367.66M

USD 4.63M

USD 40.24M

790

EPS每股收益

USD 0.6

股本和储备

USD 653.89M

USD 126.64M

债务利息支出

USD 3.7M

USD 2.3M

USD 367.66M

USD 1.06B

USD 2.92M

USD 172.75M

USD 4.63M

普通股股本

USD 39.31M

38.58

USD 571K

USD 177M

销售和管理费用

USD 83.88M

USD 150.37M

贸易债权人

USD 14.01M

应收帐款人

USD 125.64M

	净收入	更改		日
Assertio Holdings	USD -2.92M		753K	2024-09
Astellas Pharma	JPY 43.52B		56.86B	2026-03
Bristol-Myers Squibb	USD 2.68B		1.59B	2026-03
Cara Therapeutics	USD -5.53M		621K	2025-09
Coherus Biosciences	USD -37.64M		2.11M	2025-12
Heron Therapeutics	USD -2.95M		14.54M	2025-12
Ironwood Pharmaceuticals	USD 3.19M		457K	2024-12
J&J	USD 5.24B		119M	2026-03
Ligand Pharmaceuticals	USD -13.34M		58.13M	2026-03
Nektar Therapeutics	USD -36.08M		978K	2025-12
Novo Nordisk	DKK 26.89B		388M	2025-12
Omeros	USD -32.23M		23.81M	2024-09
Pacira	USD 2.92M		1.28M	2026-03
Perrigo	USD -398.6M		1.02B	2026-03
Pfizer	USD 2.69B		4.34B	2026-03
Supernus Pharmaceuticals	USD -2.29M		1.81M	2026-03
Teva Pharmaceutical Industries	USD 369M		111M	2026-03
Xeris Pharmaceuticals	USD 11.08M		10.46M	2025-12
Xoma	USD -17.24M		33.23M	2024-09
Zoetis	USD 601M		2M	2026-03